Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

31.760
-3.440-9.77%
Volume:10.06M
Turnover:330.37M
Market Cap:7.85B
PE:247.88
High:35.220
Open:35.000
Low:31.200
Close:35.200
52wk High:56.550
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.50
T/O Rate:7.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.128
ROE:-0.02%
ROA:-0.83%
PB:1.37
PE(LYR):247.88
PS:6.01

Loading ...

Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost

Stock News
·
Aug 20

AH Premium Rankings Unveiled: August 18 Market Close Data

Stock News
·
Aug 18

Dual-Listed Stock Premium Rankings: August 17 Closing Data

Stock News
·
Aug 17

CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult

THOMSON REUTERS
·
Aug 16

CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review

Stock News
·
Aug 16

CANSINOBIO Receives NMPA Acceptance and Priority Review for Five-Component DTaP Booster Vaccine

Bulletin Express
·
Aug 16

Dual-Listed Stock Premium Ranking: August 14 Market Close

Stock News
·
Aug 14

CANSINOBIO Reports Zero Share Capital Changes for July 2026; 860,000 H-Share Options Remain Outstanding

Bulletin Express
·
Aug 04

AH Share Premium and Deviation Data for July 20th

Stock News
·
Jul 20

CANSINOBIO Shares Surge on Regulatory Progress for Meningitis Vaccine

Stock News
·
Jul 20

CanSino Biologics Gets NMPA Nod to Review Supplemental Application Expanding Menhycia® Age Range

Bulletin Express
·
Jul 19

CansinoBIO Receives NMPA Acceptance for Age Extension of MenQuad Vaccine

Stock News
·
Jul 19

AH Share Premium and Deviation Rankings as of July 13th Close

Stock News
·
Jul 13

CANSINOBIO Sees Stable Share Capital in June 2026; Public Float Meets HKEX Requirement

Bulletin Express
·
Jul 03

AH Share Premium and Deviation Rankings for July 3rd

Stock News
·
Jul 03

CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Argentina

MT Newswires Live
·
Jun 25

CanSino Biologics: MCV4 Vaccine Gains Argentine Registration, Advancing Global Strategy

Bulletin Express
·
Jun 25

CansinoBIO Secures Regulatory Approval in Argentina for Meningococcal Vaccine

Stock News
·
Jun 25

CanSino Biologics Defines Governance, Capital Structure and Dividend Policy in Updated Articles of Association

Bulletin Express
·
Jun 10

CANSINOBIO Keeps Share Capital Steady in May; 2.91 Million Shares Reserved for Incentive Plans

Bulletin Express
·
Jun 02